Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00014677 | NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme | PHASE2 | COMPLETED | - | — | — | Mar 1, 2001 | Jul 1, 2008 | Jul 18, 2013 | 4 | United States |
| Name | Type | Description |
|---|---|---|
| interleukin-4 PE38KDEL cytotoxin | BIOLOGICAL | - |
| conventional surgery | PROCEDURE | - |
DISEASE CHARACTERISTICS: Histologically confirmed recurrent or progressive glioblastoma multiforme Previously treated with cytoreductive surgery Unilateral, unifocal tumor with a volume of 5-80 mL Not eligible for further radiotherapy due to prior external beam radiotherapy No multifocal, brain stem...